World-leading business angel syndicate investing in early-stage Scottish life sciences and technology companies.
Portfolio
17
companies
1nhaler
Developer of a novel paper-based dry powder inhaler platform.
Administrate
Administrate builds software to automate and manage training and learning delivery.
BDD
BDD develops drug formulation technology and provides specialist clinical trial services for the pharmaceutical sector.
Bio-Images Drug Delivery
Bio-Images Drug Delivery develops precision timed drug release technology for pharmaceutical treatments.
Biocaptiva
Biocaptiva develops technology designed to improve liquid biopsy testing for cancer management.
Bioliberty
Bioliberty builds soft robotic gloves and digital therapy platforms for stroke rehabilitation.
CSignum
CSignum enables wireless data transmission from underwater and underground environments.
Calcivis
Edinburgh biotechnology firm developing tools for the early detection and prevention of tooth decay.
Cytomos
Cytomos develops a proprietary cell analysis platform for the biopharma industry.
Earth Blox
Earth Blox provides environmental analytics to help organisations assess climate and nature risks.
Hearing Diagnostics
Developing rapid and accessible hearing test technology for clinical and retail use.
Integrated Graphene
Integrated Graphene develops a proprietary manufacturing process for high performance 3D graphene foam.
MGB Biopharma
MGB Biopharma develops a novel class of anti-infectives to tackle antibiotic resistance.
Neuranics
Neuranics develops advanced magnetic sensing technology to transform human machine interaction.
PhysioMedics
PhysioMedics develops digital self-assessment tools for musculoskeletal health.
Reactec
Reactec provides workplace health monitoring and data analytics technology for industrial workers.
iGii
Advanced materials developer scaling production of its proprietary carbon nanomaterial.
Sarah Hardy
Head of New Investments and Director
Sarah brings investment and board experience in Scottish healthcare and deep tech companies, following roles with Archangels and the Roslin Foundation.
LinkedIn
Niki McKenzie
Joint Managing Director
Niki is joint managing director at Archangel Investors Limited, having previously served as investment director at the same firm. She also holds non-executive board and chair roles across Scottish investment and public bodies.
LinkedInIan MacLeod
Chairman of the Board
Eric Young
Former Chairman
Eric brings extensive directorship experience, having previously chaired Archangels and held board roles across property, energy, and investment firms. He currently serves as a director at Our Net Energy, Airds Capital, and Miller Developments, alongside trustee and governance positions.
LinkedInTim Allan
Founder and Director of Motor Fuel Group
Tim serves as president of the Scottish Chambers of Commerce and holds non-executive roles with Archangel Investors and the University of St Andrews. He also brings board experience from Motor Fuel Group.
LinkedInMaureen Kinsler
Partner
Maureen brings intellectual property experience, having served as a partner at Marks & Clerk and principal at Schwegman Lundberg and Woessner, alongside her role as a board member at Archangel Investors.
LinkedInMike MacPhee
Retired Partner
Andrew Sealey
CEO
Andrew brings extensive experience from his long tenure as chief executive officer of Campbell Lutyens, where he now serves as chairman. He also contributes as a non-executive director at Archangel Investors Limited.
LinkedIn
David Ovens
Joint MD
David serves as joint managing director at Archangel Investors and chairs Scottish Athletics. He also holds non-executive directorships at Northern 3 Vct and UK Athletics.
LinkedInPaddy Baxter
Dan McKiddie
Investment Manager
Dan brings investment management and transaction services experience from roles at Archangel Investors, Inverleith, and PwC.
LinkedInThe funding package was led by the Scottish National Investment Bank alongside Scottish Enterprise, PXN Group, and Archangels.
"The Bank is delighted to continue to support the growth of iGii alongside our co-investors PXN Ventures and Archangels and now with the support of Scottish Enterprise. The capital that iGii has attracted is a strong indicator of the exciting potential for its Gii technology and the positive impact it could have in the world."
The funding was led by PXN Ventures with participation from Scottish Enterprise, Archangels and the European Space Agency.
"Businesses are increasingly aware that nature loss and climate risks have direct implications for financial performance, supply chains and long-term resilience. The challenge is turning complex environmental data into information that can support real business decisions. Earth Blox was built to bridge that gap, helping organisations see clearly where environmental change affects value and where investment today can strengthen future performance."
The funding round was led by Archangels to support product development and market entry.
"Oncology is an exciting and vibrant sector. The scientists and technologists have been doing incredible things based upon the samples that they’re given, but there hasn’t been any particular movement in how the samples are prepared for years. Our msX platform has the potential to revolutionise how samples are collected, allowing for larger samples, faster extraction, simpler processing, and fully automatable capabilities."
The financing will support clinical material manufacture and preparation for regulatory studies ahead of a target marketing authorisation application.
"This additional funding represents strong continued confidence in our technology platform and our progress towards commercialisation. The support from Archangels, Scottish Enterprise and BBB Investments is enabling us to advance our clinical and manufacturing capabilities as we work towards regulatory approval."
The round was led by Archangels, Par Equity, and Scottish Enterprise to accelerate product development and international growth.
"This investment reflects the growing recognition of the critical need for innovative communication solutions in the underwater IoT sector. The support from our investors will allow us to scale our operations, enhance our product offerings and help industries worldwide manage their resources more effectively. We are grateful for their trust and excited to shape the future of underwater communication."
